JBJohn Bs Booth

John Bs Booth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John Bs Booth has a total of 178 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the REGARDS Study

    by Monika M. Safford, Evgeniya Reshetnyak, Madeline R. Sterling, Joshua S. Richman, Paul M. Muntner, Raegan W. Durant, John Booth, Laura C. Pinheiro

    Background: Social determinants of health (SDH) are individually associated with incident coronary heart disease (CHD) events. Indices reflecting social deprivation have been developed for population management, but are difficult to operationalize during clinical care. We examined whether a simple count of SDH is associated with fatal incident CHD and nonfatal myocardial infarction (MI). Methods: We used data from the prospective longitudinal REasons for Geographic And Racial Differences in Stroke cohort study, a national population-based sample of community-dwelling Black and white adults age ≥45 years recruited from 2003-7. Seven SDH from the five Healthy People 2020 domains included social context (Black race, social isolation); education (educational attainment); economic stability (annual household income); neighborhood (living in a zip code with high poverty); and healthcare (lacking health insurance, living in one of the 9 US states with the least public health infrastructure). Outcomes were expert adjudicated fatal incident CHD and nonfatal MI. Results: Of 22,152 participants free of CHD at baseline, 58.8% were women, 42.0% were Blacks, 20.6% had no SDH, 30.6% had 1, 23.0% had 2, and 25.8% had ≥3. There were 463 fatal incident CHD events and 932 nonfatal MIs over median 10.7 years [IQR 6.6-12.7]. Fewer SDH were associated with nonfatal MI than with fatal incident CHD. The age-adjusted incidence per 1000 person-years increased with the number of SDH for both fatal incident CHD (0 SDH 1.30, 1 SDH 1.44, 2 SDH 2.05, ≥3 SDH 2.86) and nonfatal MI (0 SDH 3.91, 1 SDH 4.33, ≥2 SDH 5.44). Compared to those without SDH, crude and fully adjusted hazard ratios (HR) for fatal incident CHD among those with ≥3 SDH were 3.00 (95% CI 2.17, 4.15) and 1.67 (95% CI 1.18, 2.37), respectively; and that for nonfatal MI among those with ≥2 SDH were 1.57 (95% CI 1.30, 1.90) and 1.14 (0.93, 1.41), respectively. Conclusions: A greater burden of SDH was associated with a graded increase in risk of incident CHD, with greater magnitude and independent associations for fatal incident CHD. Counting the number of SDH may be a promising approach that could be incorporated into clinical care to identify individuals at high risk of CHD.


  • Open Access

    Life’s Simple 7 and Incident Hypertension: The REGARDS Study

    by Timothy B. Plante, Insu Koh, Suzanne E. Judd, George Howard, Virginia J. Howard, Neil A. Zakai, John N. BoothIII, Monika M. Safford, Paul Muntner, Mary Cushman

    Background: The Life’s Simple 7 (LS7) metric incorporates health behaviors (body mass index, diet, smoking, physical activity) and health factors (blood pressure, cholesterol, glucose) to estimate an individual’s level of cardiovascular health. The association between cardiovascular health and incident hypertension is unresolved. Hypertension’s threshold was recently lowered and it is unclear if better cardiovascular health is associated with lower risk of incident hypertension with the updated threshold or in a multirace cohort. We sought to assess the association between better LS7 score and risk of incident hypertension among Black and White adults using a 130/80 mm Hg hypertension threshold. Methods and Results: We determined the association between LS7 metric and incident hypertension in the REGARDS (Reasons for Geographic and Racial Disparities in Stroke) study, including participants free of baseline hypertension (2003–2007) who completed a second visit between 2013 and 2016. Hypertension was defined as systolic/diastolic blood pressure ≥130/80 mm Hg or antihypertensive medication use. Each LS7 component was assigned 0 (poor), 1 (intermediate), or 2 (ideal) points. We generated a 14‐point score by summing points. Among 2930 normotensive participants (20% Black, 80% White), the median (25th–75th percentiles) LS7 total score was 9 (8–10) points. Over a median follow‐up of 9 years, 42% developed hypertension. In the fully adjusted model, each 1‐point higher LS7 score had a 6% lower risk of incident hypertension (risk ratio, 0.94 per 1 point; 95% CI, 0.92–0.96). Conclusions: Better cardiovascular health was associated with lower risk of incident hypertension using a 130/80 mm Hg hypertension threshold among Black and White adults.


  • Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension

    by Aisha T. Langford, Oluwasegun P. Akinyelure, Tony L. Moore, George Howard, Yuan-I Min, William B. Hillegass, Adam P. Bress, Gabriel S. Tajeu, Mark Butler, Byron C. Jaeger, et al.

    Resistant hypertension, defined as blood pressure levels above goal while taking ≥3 classes of antihypertensive medication or ≥4 classes regardless of blood pressure level, is associated with increased cardiovascular disease risk. The 2018 American Heart Association Scientific Statement on Resistant Hypertension recommends healthy lifestyle habits and thiazide-like diuretics and mineralocorticoid receptor antagonists for adults with resistant hypertension. The term apparent treatment-resistant hypertension (aTRH) is used when pseudoresistance cannot be excluded. We estimated the use of healthy lifestyle factors and recommended antihypertensive medication classes among US Black adults with aTRH. Data were pooled for Black participants in the JHS (Jackson Heart Study) in 2009 to 2013 (n=2496) and the REGARDS study (Reasons for Geographic and Racial Differences in Stroke) in 2013 to 2016 (n=3786). Outcomes included lifestyle factors (not smoking, not consuming alcohol, ≥75 minutes of vigorous-intensity or ≥150 minutes of moderate or vigorous physical activity per week, and body mass index 2 ) and recommended antihypertensive medications (thiazide-like diuretics and mineralocorticoid receptor antagonists). Overall, 28.3% of participants who reported taking antihypertensive medication had aTRH. Among participants with aTRH, 14.5% and 1.2% had ideal levels of 3 and 4 of the lifestyle factors, respectively. Also, 5.9% of participants with aTRH reported taking a thiazide-like diuretic, and 9.8% reported taking a mineralocorticoid receptor antagonist. In conclusion, evidence-based lifestyle factors and recommended pharmacological treatment are underutilized in Black adults with aTRH. Increased use of lifestyle recommendations and antihypertensive medication classes specifically recommended for aTRH may improve blood pressure control and reduce cardiovascular disease–related morbidity and mortality among US Black adults. Graphic A graphic abstract is available for this article.


  • Racial Differences in Maintaining Optimal Health Behaviors Into Middle Age

    by John N. Booth, Norrina B. Allen, David Calhoun, April P. Carson, Luqin Deng, David C. Goff, David T. Redden, Jared P. Reis, Daichi Shimbo, James M. Shikany, et al.


  • Open Access

    Race and sex differences in asleep blood pressure: The Coronary Artery Risk Development in Young Adults (CARDIA) study

    by John N. Booth, D. Edmund Anstey, Natalie A. Bello, Byron C. Jaeger, Daniel N. Pugliese, Stephen Justin Thomas, Luqin Deng, James M. Shikany, Donald Lloyd‐Jones, Joseph E. Schwartz, et al.

    Nocturnal hypertension and non‐dipping blood pressure are each associated with increased risk of cardiovascular disease. We determined differences in nocturnal hypertension and non‐dipping systolic/diastolic blood pressure among black and white men and women who underwent 24‐hour ambulatory blood pressure monitoring at the Coronary Artery Risk Development in Young Adults study Year 30 Exam in 2015‐2016. Asleep and awake periods were determined from actigraphy complemented by sleep diaries. Nocturnal hypertension was defined as mean asleep systolic/diastolic blood pressure ≥ 120/70 mm Hg. Non‐dipping systolic and diastolic blood pressure, separately, were defined as a decline in awake‐to‐asleep blood pressure < 10%. Among 767 participants, the prevalence of nocturnal hypertension was 18.4% and 44.4% in white and black women, respectively, and 36.4% and 59.9% in white and black men, respectively. After multivariable adjustment and compared with white women, the prevalence ratio (95% confidence interval) for nocturnal hypertension was 1.65 (1.18‐2.32) for black women, 1.63 (1.14‐2.33) for white men, and 2.01 (1.43‐2.82) for black men. The prevalence of non‐dipping systolic blood pressure was 21.5% and 41.0% in white and black women, respectively, and 20.2% and 37.9% in white and black men, respectively. Compared with white women, the multivariable‐adjusted prevalence ratio (95% confidence interval) for non‐dipping systolic blood pressure was 1.66 (1.18‐2.32), 0.91 (0.58‐1.42) and 1.66 (1.15‐2.39) among black women, white men, and black men, respectively. Non‐dipping diastolic blood pressure did not differ by race‐sex groups following multivariable adjustment. In conclusion, black women and men have a high prevalence of nocturnal hypertension and non‐dipping systolic blood pressure.


  • Abstract P170: Morning Surge and Cardiovascular Events in African Americans: The Jackson Heart Study

    by John N Booth, Marwah Abdalla, Mario Sims, Mark Butler, Tanya Spruill, Paul Muntner, Daichi Shimbo

    Introduction: A larger sleep-trough morning surge, defined as the mean two-hour post-awakening blood pressure (BP) minus the lowest asleep BP, has been associated with cardiovascular disease (CVD) events in Asians and Europeans. High asleep BP in African Americans (AA) may preclude a morning surge and an association with CVD due to a smaller BP change upon awakening. Objective: Determine the association of morning surge with CVD events in AAs. Methods: We analyzed participants from the Jackson Heart Study, a community-based cohort of AAs, with a complete 24-hour ambulatory BP monitoring recording and self-report asleep and awake times at baseline in 2000-2004 (n=767). Participants were grouped into tertiles of sleep-trough morning surge, two-hour post-awakening BP and lowest sleep BP. CVD events (nonfatal/fatal stroke, nonfatal myocardial infarction or fatal coronary heart disease; n=61) through December 2012 were adjudicated. Results: Participants’ mean age was 59.2 years and 32.1% were male. Multivariable adjusted hazard ratios (95% CI) for CVD events associated with Tertile 2 and 3 versus Tertile 1 of morning systolic BP (SBP) surge were 1.45 (0.71 – 2.97) and 2.03 (0.98 – 4.23), respectively; of post-awakening SBP were 2.01 (0.81 – 4.99) and 4.41 (1.85 – 10.50), respectively; and of lowest asleep SBP were 1.55 (0.68 – 3.52) and 2.22 (0.96 – 5.14), respectively ( Table ). Also, there was a graded increasing risk for CVD associated with Tertile 2 and 3 versus Tertile 1 of post-awakening diastolic BP (DBP), but not morning DBP surge and lowest asleep DBP. Conclusion: Higher morning SBP surge, post-awakening SBP and lowest asleep SBP and DBP were associated increased CVD risk in AAs.

  • Open Access

    2039

    by Adam Bress, Lisandro D. Colantonio, John N. Booth, Tanya M. Spruill, Joseph Ravenell, Mark Butler, Amanda J. Shallcross, Samantha R. Seals, Kristi Reynolds, Gbenga Ogedegbe, et al.

    OBJECTIVES/SPECIFIC AIMS: Clinical guidelines recommend using predicted atherosclerotic cardiovascular disease (ASCVD) risk to inform treatment decisions. The objective was to compare the contribution of changes in modifiable risk factors Versus aging to the development of high 10-year predicted ASCVD risk. METHODS/STUDY POPULATION: Prospective follow-up of the Jackson Heart Study, an exclusively African-American cohort, at visit 1 (2000–2004) and visit 3 (2009–2012). Analyses included 1115 African-American participants without a high 10-year predicted ASCVD risk (<7.5%), hypertension, diabetes, or ASCVD at visit 1. We used the Pooled Cohort equations to calculate the incidence of high (≥7.5%) 10-year predicted ASCVD risk at visit 3. We recalculated the percentage with a high 10-year predicted ASCVD risk at visit 3 assuming each risk factor [age, systolic blood pressure (SBP), antihypertensive medication use, diabetes, smoking, total and high-density lipoprotein cholesterol], one at a time, did not change from visit 1. RESULTS/ANTICIPATED RESULTS: The mean age at visit 1 was 45.2±9.5 years. Overall, 30.9% (95% CI 28.3%–33.4%) of participants developed high 10-year predicted ASCVD risk. Aging accounted for 59.7% (95% CI 54.2%–65.1%) of the development of high 10-year predicted ASCVD risk compared with 32.8% (95% CI 27.0%–38.2%) for increases in SBP or antihypertensive medication initiation and 12.8% (95% CI 9.6%–16.5%) for incident diabetes. Among participants <50 years, the contribution of increases in SBP or antihypertensive medication initiation was similar to aging. DISCUSSION/SIGNIFICANCE OF IMPACT: Increases in SBP and antihypertensive medication initiation are major contributors to the development of high 10-year predicted ASCVD risk in African Americans, particularly among younger adults.

  • Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg

    by Gabriel S. Tajeu, John N. Booth, Lisandro D. Colantonio, Rebecca F. Gottesman, George Howard, Daniel T. Lackland, Emily C. O’bRien, Suzanne Oparil, Joseph Ravenell, Monika M. Safford, et al.

    Background: Data from before the 2000s indicate that the majority of incident cardiovascular disease (CVD) events occur among US adults with systolic and diastolic blood pressure (SBP/DBP) ≥140/90 mm Hg. Over the past several decades, BP has declined and hypertension control has improved. Methods: We estimated the percentage of incident CVD events that occur at SBP/DBP <140/90 mm Hg in a pooled analysis of 3 contemporary US cohorts: the REGARDS study (Reasons for Geographic and Racial Differences in Stroke), the MESA (Multi-Ethnic Study of Atherosclerosis), and the JHS (Jackson Heart Study) (n=31 856; REGARDS=21 208; MESA=6779; JHS=3869). Baseline study visits were conducted in 2003 to 2007 for REGARDS, 2000 to 2002 for MESA, and 2000 to 2004 for JHS. BP was measured by trained staff using standardized methods. Antihypertensive medication use was self-reported. The primary outcome was incident CVD, defined by the first occurrence of fatal or nonfatal stroke, nonfatal myocardial infarction, fatal coronary heart disease, or heart failure. Events were adjudicated in each study. Results: Over a mean follow-up of 7.7 years, 2584 participants had incident CVD events. Overall, 63.0% (95% confidence interval [CI], 54.9−71.1) of events occurred in participants with SBP/DBP <140/90 mm Hg; 58.4% (95% CI, 47.7−69.2) and 68.1% (95% CI, 60.1−76.0) among those taking and not taking antihypertensive medication, respectively. The majority of events occurred in participants with SBP/DBP <140/90 mm Hg among those <65 years of age (66.7%; 95% CI, 60.5−73.0) and ≥65 years of age (60.3%; 95% CI, 51.0−69.5), women (61.4%; 95% CI, 49.9−72.9) and men (63.8%; 95% CI, 58.4−69.1), and for whites (68.7%; 95% CI, 66.1−71.3), blacks (59.0%; 95% CI, 49.5−68.6), Hispanics (52.7%; 95% CI, 45.1−60.4), and Chinese-Americans (58.5%; 95% CI, 45.2−71.8). Among participants taking antihypertensive medication with SBP/DBP <140/90 mm Hg, 76.6% (95% CI, 75.8−77.5) were eligible for statin treatment, but only 33.2% (95% CI, 32.1−34.3) were taking one, and 19.5% (95% CI, 18.5−20.5) met the SPRINT (Systolic Blood Pressure Intervention Trial) eligibility criteria and may benefit from a SBP target goal of 120 mm Hg. Conclusions: Although higher BP levels are associated with increased CVD risk, in the modern era, the majority of incident CVD events occur in US adults with SBP/DBP <140/90 mm Hg. While absolute risk and cost-effectiveness should be considered, additional CVD risk-reduction measures for adults with SBP/DBP <140/90 mm Hg at high risk for CVD may be warranted.


  • Open Access

    Cardiovascular Health and Incident Hypertension in Blacks

    by John N. Booth, Marwah Abdalla, Rikki M. Tanner, Keith M. Diaz, Samantha G. Bromfield, Gabriel S. Tajeu, Adolfo Correa, Mario Sims, Gbenga Ogedegbe, Adam P. Bress, et al.

    Several modifiable health behaviors and health factors that comprise the Life’s Simple 7—a cardiovascular health metric—have been associated with hypertension risk. We determined the association between cardiovascular health and incident hypertension in JHS (the Jackson Heart Study)—a cohort of blacks. We analyzed participants without hypertension or cardiovascular disease at baseline (2000–2004) who attended ≥1 follow-up visit in 2005 to 2008 or 2009 to 2012 (n=1878). Body mass index, physical activity, diet, cigarette smoking, blood pressure (BP), total cholesterol, and fasting glucose were assessed at baseline and categorized as ideal, intermediate, or poor using the American Heart Association’s Life’s Simple 7 definitions. Incident hypertension was defined at the first visit wherein a participant had systolic BP ≥140 mm Hg, diastolic BP ≥90 mm Hg, or self-reported taking antihypertensive medication. The percentage of participants with ≤1, 2, 3, 4, 5, and 6 ideal Life’s Simple 7 components was 6.5%, 22.4%, 34.4%, 25.2%, 10.0%, and 1.4%, respectively. No participants had 7 ideal components. During follow-up (median, 8.0 years), 944 (50.3%) participants developed hypertension, including 81.3% with ≤1 and 11.1% with 6 ideal components. The multivariable-adjusted hazard ratios (95% confidence interval) for incident hypertension comparing participants with 2, 3, 4, 5, and 6 versus ≤1 ideal component were 0.80 (0.61–1.03), 0.58 (0.45–0.74), 0.30 (0.23–0.40), 0.26 (0.18–0.37), and 0.10 (0.03–0.31), respectively ( P trend <0.001). This association was present among participants with baseline systolic BP <120 mm Hg and diastolic BP <80 mm Hg and separately systolic BP 120 to 139 mm Hg or diastolic BP 80 to 89 mm Hg. Blacks with better cardiovascular health have lower hypertension risk.


  • Trends in Prehypertension and Hypertension Risk Factors in US Adults

    by John N. Booth, Jiexiang Li, Lu Zhang, Liwei Chen, Paul Muntner, Brent Egan

    Prehypertension is associated with increased risk for hypertension and cardiovascular disease. Data are limited on the temporal changes in the prevalence of prehypertension and risk factors for hypertension and cardiovascular disease among US adults with prehypertension. We analyzed data from 30 958 US adults ≥20 years of age who participated in the National Health and Nutrition Examination Surveys between 1999 and 2012. Using the mean of 3 blood pressure (BP) measurements from a study examination, prehypertension was defined as systolic BP of 120 to 139 mm Hg and diastolic BP P trend=0.007). During this time period, the prevalence of several risk factors for cardiovascular disease and incident hypertension increased among US adults with prehypertension, including prediabetes (9.6% to 21.6%), diabetes mellitus (6.0% to 8.5%), overweight (33.5% to 37.3%), and obesity (30.6% to 35.2%). There was a nonstatistically significant increase in no weekly leisure-time physical activity (40.0% to 43.9%). Also, the prevalence of adhering to the Dietary Approaches to Stop Hypertension eating pattern decreased (18.4% to 11.9%). In contrast, there was a nonstatistically significant decline in current smoking (25.9% to 23.2%). In conclusion, the prevalence of prehypertension has decreased modestly since 1999–2000. Population-level approaches directed at adults with prehypertension are needed to improve risk factors to prevent hypertension and cardiovascular disease.